News for Healthier Living

Cleveland Researchers Discover Enzyme That Controls Both Weight Gain and Cholesterol Levels in Animal Models

Rates of obesity and associated fatty liver disease have risen as the world increasingly adopts energy-dense diets and sedentary lifestyles. Cleveland research team has discovered a new enzyme that is required to make fat. Blocking the enzyme prevented weight gain and lowered cholesterol. A three-in-one drug is being developed to treat obesity, fatty liver disease, and cardiovascular disease.

December 23, 2025


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025